Cerebral thrombosis is a common neurological disease. The acute phase of cerebral thrombosis is about 14 days, and it gradually enters the recovery phase after 14 days of onset. During the acute period, especially if there is an indication for thrombolysis within 4.5 hours of onset and contraindications to thrombolysis are excluded, thrombolytic therapy should be actively performed. If there is no indication for thrombolysis, antiplatelet aggregation or anticoagulation therapy, as well as lipid regulation therapy with statins, should be actively administered. Antiplatelet or anticoagulation therapy should also be continued during the recovery period of cerebral thrombosis so that cerebral thrombosis can be controlled and the recurrence rate of cerebral thrombosis can be reduced. Assessment of risk factors for cerebral thrombosis should be performed to reduce the occurrence of risk factors and thus reduce the occurrence of cerebral thrombosis.